Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
185.60    0.50 (0.27%)
Bid:
185.45
Ask:
185.55
Spread: 0.10 (0.054%)
Market Cap: £8.41b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Directorate Change

22 Sep 2025 07:00

RNS Number : 1216A
Centrica PLC
22 September 2025
 

22 September 2025

Centrica plc

('Centrica' or 'the Company')

Centrica appoints Non-Executive Director

Centrica is pleased to announce the appointment of Frank Mastiaux as a Non-Executive Director of the Company with effect from 22 September 2025. Frank will also join the Company's Safety, Environment and Sustainability Committee (SESC).

Frank is an experienced executive and board member with over three decades in the energy industry. He served as CEO of Energie Baden-Württemberg AG (EnBW) from 2012 to 2022, where he led a strategic transformation that significantly increased the company's market capitalisation and positioned it as a leader in renewable energy. Prior to that, he held senior roles at BP and E.ON, including CEO of E.ON Climate & Renewables and CEO of BP's global LPG business.Frank currently serves as Chair of Sunfire SE, a hydrogen technology company, and is an advisory board member at Boehringer Ingelheim. He was previously a Supervisory Board member at Alstom Group. He holds a PhD in Analytical Chemistry from the University of Duisburg.

Kevin O'Byrne, Chair of Centrica, said:"I am delighted to welcome Frank to the Board. Frank brings a wealth of experience from across the energy sector, having led major transformations at some of Europe's largest utilities. His deep understanding of both legacy and low-carbon energy systems, combined with his strategic leadership, will be invaluable as Centrica continues to deliver on its strategy."

Frank Mastiaux said:

"I am very pleased to join Centrica as a Non-Executive Director. Centrica's commitment to navigating the energy transition and its focus on sustainability align with my values and experience. I look forward to working with the Board to support the talented team at Centrica to drive innovation and growth in the energy sector."

Notes

1.

This announcement is made pursuant to UKLR 6.4.8. The Company confirms that there are no additional matters requiring disclosure under UKLR 6.4.8.

2.

At the date of this announcement, Frank Mastiaux has no beneficial interest in the ordinary shares of Centrica.

 

ENDS

Enquiries:

Investors and AnalystsE: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALLMATMTIBBMA
Date   Source Headline
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.